SFS
BIS icon

Sowell Financial Services’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Sowell Financial Services’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,143
Closed -$54K – 3109
2020
Q4 		$54K Buy
+1,143
New +$62.3K ﹤0.01% 1361

Other funds holding BIS

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sowell Financial Services's BIS Position: Q1 2021 in Review

Sowell Financial Services sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q1 2021, closing a stake of 1,143 shares — an estimated $54K sold.

Sowell Financial Services first reported a position in BIS in Q4 2020 and held it in 1 quarter. The position peaked at $54K in Q4 2020. 10 funds tracked by Wall St. Rank hold BIS as of Q1 2021.

  • Sowell Financial Services reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,143 ProShares UltraShort NASDAQ Biotechnology shares in Q1 2021, an estimated $54K.
  • Sowell Financial Services first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q4 2020 and held it in 1 quarter.
  • Sowell Financial Services's ProShares UltraShort NASDAQ Biotechnology position peaked at $54K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.